Article Information
PubMed
Published By
History
- Received January 23, 2019
- Revision received April 1, 2019
- Accepted April 2, 2019
- Published online April 30, 2019.
Copyright & Usage
Copyright © 2019 Day et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Stephen M. Day1,2,
- Wenzhong Yang1,
- Xin Wang1,
- Jennifer E. Stern1,
- Xueyan Zhou1,
- Shannon L. Macauley1 and
- Tao Ma1,2,3
- 1Departments of Internal Medicine and Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157
- 2Department of Integrative Physiology & Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157
- 3Department of Neurobiology and Anatomy, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157
- Correspondence should be addressed to Tao Ma at Tma{at}wakehealth.edu.
Author contributions
Author contributions: S.M.D. and T.M. designed research; S.M.D., W.Y., J.E.S., X.Z., and S.L.M. performed research; S.M.D., W.Y., X.W., J.E.S., S.L.M., and T.M. analyzed data; S.M.D. and T.M. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by National Institutes of Health Grants R01 AG055581, R01 AG056622 (T.M.), the Alzheimer’s Association grant NIRG-15-362799 (T.M.), and the BrightFocus Foundation Grant A2017457S.
Funding
NIH
R01 AG055581; R01 AG056622Alzheimer's Association
NIRG-15-362799BrightFocus Foundation
A2017457S
Other Version
- You are viewing the most recent version of this article.
- previous version (April 30, 2019).
Article usage
In this issue
Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome
